Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies

BACKGROUND: Coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) is being extensively investigated as a treatment, with mixed results to date. Overall, there has been a generalized lack of appropriateness in prescriptions, which, in the field of transfusion medicine, is termed patient-blood...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Microbiol Infect
Hauptverfasser: Focosi, Daniele, Maggi, Fabrizio, Franchini, Massimo, Aguzzi, Adriano, Lanza, Maria, Mazzoni, Alessandro, Menichetti, Francesco
Format: Artigo
Sprache:Inglês
Veröffentlicht: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Schlagworte:
Narrative Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8052606/
https://ncbi.nlm.nih.gov/pubmed/33878505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2021.04.003
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge